Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorStem Cell TransplantationCombined Modality TherapyLeukapheresisAntigens, CD34Hematologic NeoplasmsBlood Component RemovalMultiple MyelomaCyclophosphamideBone Marrow TransplantationStem CellsAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem CellsGraft vs Host DiseaseBusulfanMyeloablative AgonistsTreatment OutcomeGraft SurvivalLymphoma, Non-HodgkinEtoposideRemission InductionAntineoplastic Agents, AlkylatingRecurrenceThiotepaCarmustineSalvage TherapyCytophagocytosisVincristineHematopoiesisIfosfamideCytarabineHodgkin DiseaseDisease-Free SurvivalCord Blood Stem Cell TransplantationAmyloidosisTransplantation ChimeraRetrospective StudiesTissue DonorsWhole-Body IrradiationSurvival RateNeoplasmsSurvival AnalysisTime FactorsLiver TransplantationDoxorubicinInfectionImmunosuppressive AgentsHistocompatibilityLymphoma, T-CellBone Marrow PurgingPrednisoneHistocompatibility TestingPlatelet CountTransplantation, IsogeneicLeukemia, Myeloid, AcutePOEMS SyndromeDexamethasoneFollow-Up StudiesBlood Cell CountCarboplatinLeukemiaVidarabineRecombinant ProteinsAntineoplastic AgentsLymphomaEmbryonic Stem CellsFeasibility StudiesProspective StudiesKidney TransplantationMesenchymal Stem Cell TransplantationAdult Stem CellsCell TransplantationBlood CellsCytomegalovirus InfectionsBlood Transfusion, AutologousGraft vs Leukemia EffectCell DifferentiationFatal OutcomeMyelodysplastic SyndromesCell SeparationBone MarrowImmunophenotypingCells, CulturedAnemia, AplasticFlow CytometryPrognosisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveT-LymphocytesPluripotent Stem CellsLymphocyte DepletionBone Marrow CellsImmunosuppressionHLA Antigens